Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Research-grade specs Components: GHK-Cu (50 mg) + BPC-157 (10 mg) + TB-500 (10 mg) + KPV (10 mg) Total strength: 80 mg per vial Format: Lyophilized powder, single-vial blend Pathways studied: Matrix remodelling (GHK-Cu), cell migration (BPC-157, TB-500), cytokine signalling (KPV) Studied applications Multi-pathway combination research Comparative single-compound vs combination studies Receptor and cytokine pathway interaction research Copper-peptide and tripeptide comparative research Quality & trust 99% HPLC purity, third-party tested Mass spectrometry identity confirmation LAL endotoxin testing on every batch Batch-specific Certificate of Analysis included cGMP manufactured in Dallas, Texas (USA) USA same-day shipping (orders before 2pm CT M-F) Free domestic shipping on orders over $200 Storage & handling Store lyophilized vials refrigerated at 28C, protected from light and heat Reconstitute with bacteriostatic water
Brenipatide is unlikely to be approved for obesity in any meaningful timeframe
It is also believed to help individuals on a diet by reducing fatigue and hunger
Reduce systemic inflammation Peptides such as Thymosin Beta-4 help regulate immune response and inflammation
US$ 24.30
US$ 27.04
US$ 26.21
US$ 20.43
US$ 25.90
US$ 20.11
US$ 27.76
